Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.

Blood cancer journal·2026
Same author

Re: Durvalumab in combination with BCG for BCG-naive, high risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.

European urology·2026
Same author

Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.

Blood advances·2026
Same author

Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses.

BJUI compass·2026
Same author

Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Beyond the Scalpel: Unpacking the Difference Between Good Surgeons and Good Leaders.

Urology·2025
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
Same journal

Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio.

Urologic oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K

Protocol-driven same day discharge for robotic radical prostatectomy.

Emily H Roebuck1, Lila G McGrath1, Myra Robinson2

  • 1Wake Forest School of Medicine, Winston Salem, NC.

Urologic Oncology
|November 12, 2025
PubMed
Summary
This summary is machine-generated.

Same-day discharge (SDD) after robot-assisted laparoscopic prostatectomy (RALP) is safe and effective. A standardized SDD protocol improved care consistency without increasing adverse events like readmissions or complications.

Keywords:
Assessment, patient outcomesComplications, postoperativeDischarge planningHospital readmissionProstatectomy

More Related Videos

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

793
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

793
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Area of Science:

  • Urology
  • Surgical Oncology
  • Health Services Research

Background:

  • Robot-assisted laparoscopic prostatectomy (RALP) typically involves a 24-48 hour hospital stay.
  • Standardized protocols for same-day discharge (SDD) after RALP are being explored to optimize patient care and resource utilization.

Purpose of the Study:

  • To evaluate the safety and efficacy of implementing a standardized same-day discharge (SDD) protocol for patients undergoing RALP.
  • To compare outcomes of SDD versus traditional inpatient stay (IP-RALP) following RALP.

Main Methods:

  • A retrospective cohort study of 220 RALP patients was conducted.
  • A standardized SDD protocol was implemented, expanding eligibility and formalizing perioperative management.
  • Patients were analyzed in same-day discharge (SDD) and inpatient (IP-RALP) groups, with outcomes compared using appropriate statistical tests.

Main Results:

  • 132 of 149 patients (88.6%) initiated on the SDD protocol were successfully discharged the same day.
  • No significant differences were observed in emergency department visits, 24-hour readmissions, or overall complication rates between SDD and IP-RALP groups.
  • While 30-day readmissions were slightly higher in the SDD group (9.1% vs. 4.6%), this was not statistically significant. The protocol improved POD1 contact rates and discharge medication management consistency.

Conclusions:

  • Same-day discharge (SDD) following RALP is a safe strategy, not associated with increased risks of adverse events.
  • Formalizing an SDD protocol enhances consistency in discharge processes and perioperative management.
  • Further research into preoperative risk stratification is recommended for tailored SDD care plans.